Key facts
- This page summarizes Sailaja Puttagunta's Form 4 filing for Iterum Therapeutics plc (ITRM).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 04 Dec 2023, 17:00.
Sailaja Puttagunta - 01 Dec 2023 Form 4 Insider Report for Iterum Therapeutics plc (ITRM)
- Reporting relationship
- Chief Medical Officer
- Issuer ticker
- ITRM
- Reported as of
- 01 Dec 2023
- Net transaction value
- -$6,218
- SEC form
- 4
- Accepted by SEC
- 04 Dec 2023, 17:00:26 UTC
- Prior SEC filing
- 03 Apr 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Sailaja Puttagunta
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Filing notes and source
Key filing fact
Sailaja Puttagunta filed Form 4 for Iterum Therapeutics plc (ITRM) on 04 Dec 2023.
Change
- Previous filing in this sequence was filed on 03 Apr 2023.
- Current net transaction value: -$6,218.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ITRM
transaction
Ordinary Shares
Award
- Transaction value
- $0
- Shares
- +8,333
- Change %
- +168%
- Price
- $0.000000
- Shares after
- 13,302
- Date
- 01 Dec 2023
- Ownership
- Direct
- Footnotes
- F1, F2
ITRM
transaction
Ordinary Shares
Tax liability
- Transaction value
- -$6,218
- Shares
- -2,933
- Change %
- -22%
- Price
- $2.12
- Shares after
- 10,369
- Date
- 01 Dec 2023
- Ownership
- Direct
- Footnotes
- F3
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ITRM
transaction
Derivative
Restricted Share Units
Options Exercise
- Transaction value
- $0
- Shares
- -8,333
- Change %
- -33%
- Price
- $0.000000
- Shares after
- 16,666
- Date
- 01 Dec 2023
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 8,333
- Exercise price
- Footnotes
- F2, F4, F5
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 5 footnotes
Footnote F1
On August 17, 2022 the Issuer effected a 1 for 15 reverse share split (the "Reverse Share Split"). The number of ordinary shares reported in this Form 4 have been adjusted to reflect the Reverse Share Split.
Footnote F2
Restricted share units ("RSUs") converted into ordinary shares on a one-for-one basis upon vesting of the RSUs.
Footnote F3
Represents the ordinary shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted RSUs.
Footnote F4
The number of RSUs reported on this Form 4 have been adjusted to reflect the Reverse Share Split.
Footnote F5
On December 1, 2021, the reporting person was granted an award of 33,333 RSUs, 25% of which vested on December 1, 2022, with a further 25% having vested on December 1, 2023.